InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,917.08
(
1.00%
)
Post# of 252426
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: dav1234 post# 164817

Tuesday, 08/27/2013 7:35:12 AM

Tuesday, August 27, 2013 7:35:12 AM

Post# of 252426
OncoGenex initiates panreatic cancer trial
OncoGenex (OGXI) initiates a Phase 2 study of an apatorsen/ Abraxane/ gemcitabine combo in patients with previously untreated metastatic pancreatic cancer.Primary endpoint is overall survival.Also evaluated: Progression-free survival, tumor response rates, safety, tolerability, and the effect of therapy on heat shock protein 27 levels

http://seekingalpha.com/news-article/7427902-oncogenex-announces-that-the-rainier-clinical-trial-evaluating-apatorsen-ogx-427-in-combination-with-abraxane-plus-gemcitabine-in-patients-with-metastatic-pancreatic-cancer-is-now-open-for-enrollment
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up